EN
CN EN

Successful FDA inspection at Yangzhou Aurisco

Release time：2023-08-11

Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).


See the attachment for details.


Successful FDA inspection at Aurisco’s manufacturing site in Yangzhou, China

Back to list
Next：Aurisco will attend CPHI Korea 2023 Last：Experts visit Yangzhou Aurisco

About
Us
Who we are
Milestone
Corporate culture
Corporate social responsibility (CSR)
Press releases
Sustainability
& Compliance
Sustainability and Compliance
Quality system
EHS
Carbon Neutrality Goals
Supply Security
R&D,Science
Innovation
Innovation and IP Security
R&D Center
Our Science
Our Pipeline
Tech Platforms
Product
& Service
API
FDF
CRO&CDMO
Manufacturing
Sites
Facilities
Investor
Relations
Secretary's Mailbox
CompanyProfile
EquityStructure
CompanyAnnouncement
Contact Us
Job openings
Career Opportunity
Contact us
Follow Aoruite WeChat official account
版权所有 奥锐特药业股份有限公司 Copyright © 2020 AURISCO.All Rights Reserved 浙ICP备17058154号-1 Legal Notice
Enterprise mailbox